
<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Proteus Syndrome Medical Illustration</title>
    <style>
        body {
            font-family: Arial, sans-serif;
            margin: 40px;
            display: flex;
        }
        img {
            max-width: 30%;
            height: 100%;
            margin-right: 20px;
        }
        .content {
            max-width: 70%;
        }
    </style>
</head>
<body>
    <img src="../images/ProteusSyndrome2needtofindsource.jpg" alt="Proteus Syndrome (2)">
    
    <div class="content">
        <h1>Medical Illustration of Proteus Syndrome</h1>
        
        <h2>Artist/Group/Tribe</h2>
        <p>This medical illustration represents the work of 19th-century scientific illustrators who specialized in documenting rare medical conditions for educational and diagnostic purposes. These artists worked within medical institutions and publishing houses, creating detailed anatomical and pathological representations that bridged art and science. The precise engraving technique suggests the work of professional medical illustrators who collaborated closely with physicians to accurately document unusual cases for medical literature.</p>

        <h2>Historical and Socio-Cultural Context</h2>
        <p>This illustration dates to the late 19th century, during the golden age of medical illustration when scientific documentation through visual means was becoming increasingly sophisticated. This period marked a transition from purely descriptive medicine to more systematic approaches to understanding rare diseases. The dual portrait format reflects the era's emphasis on comprehensive clinical documentation, showing both profile and three-quarter views to capture the full extent of physical manifestations. Medical illustrations during this time served crucial educational functions in an era before photography became standard in medical practice.</p>

        <h2>Symbolism and/or Iconography</h2>
        <p>The circular framing of each portrait creates a sense of scientific objectivity while maintaining the dignity of the subject. The dual presentation format symbolizes the medical practice of comprehensive examination from multiple angles. The detailed rendering of facial deformities serves both as clinical documentation and as a testament to the human condition's complexity. The artistic choice to maintain realistic proportions while clearly depicting pathological features reflects the balance between scientific accuracy and human representation.</p>

        <h2>Stylistic Significance</h2>
        <p>The illustration employs fine line engraving techniques characteristic of 19th-century medical texts. The use of crosshatching creates depth and dimension, while careful attention to light and shadow emphasizes the three-dimensional nature of the skeletal and soft tissue overgrowth. The composition follows principles of scientific illustration: clear delineation of abnormal features, consistent scaling, and neutral background to focus attention on the pathological manifestations. The bilateral symmetry of the layout reinforces the systematic nature of medical observation.</p>

        <h2>Social/Cultural Inequities</h2>
        <p>Medical illustrations of this era often reflect the power dynamics between physicians and patients, particularly those with visible differences who were frequently subjects of medical curiosity. Individuals with rare conditions like Proteus syndrome were often displayed in medical literature without consideration of their autonomy or dignity. The clinical gaze embedded in such illustrations contributed to the medicalization and objectification of people with disabilities, reducing complex human experiences to pathological specimens for study.</p>

        <h2>Description of Disease & Etiology</h2>
        <p>Proteus syndrome is a rare congenital disorder characterized by asymmetric overgrowth of bones, skin, and other tissues. The condition results from somatic mutations in the AKT1 gene, which regulates cell growth and proliferation. These mutations occur during early embryonic development, leading to mosaic patterns of affected and unaffected tissues. The syndrome affects fewer than 1 in 1 million people worldwide and manifests as progressive, disproportionate growth of various body parts, particularly affecting the skull, limbs, and skin.</p>

        <h2>Pathology Signs/Signifiers of Illness</h2>
        <p>The illustration clearly demonstrates characteristic features of Proteus syndrome: asymmetric cranial enlargement, bony overgrowth creating facial distortion, and what appears to be cutaneous manifestations. The left figure shows pronounced cranial asymmetry and facial deformity, while the right figure displays extensive soft tissue overgrowth affecting the scalp and facial regions. These manifestations represent the hallmark asymmetric, progressive nature of the condition, with overgrowth affecting bone, connective tissue, and skin in a mosaic pattern.</p>

        <h2>Treatment</h2>
        <p>During the 19th century when this illustration was created, treatment options were extremely limited. Management focused primarily on symptomatic care and surgical intervention for functional impairments. Modern treatment approaches include multidisciplinary care involving orthopedic surgery, plastic surgery, and supportive therapies. Recent research into mTOR pathway inhibitors shows promise for slowing abnormal growth, though treatment remains primarily symptomatic and supportive, focusing on maintaining function and addressing complications as they arise.</p>

        <h2>Social Determinants of Illness</h2>
        <p>Proteus syndrome's impact extends beyond medical manifestations to encompass significant social challenges. Historical attitudes toward physical difference often resulted in social isolation and exploitation. Access to specialized medical care remains limited by geographic and economic factors, as the condition requires expertise from multiple medical specialties. Educational opportunities and social integration continue to be affected by societal attitudes toward visible differences, highlighting the ongoing need for disability advocacy and inclusive social policies.</p>

        <h2>References and Citations</h2>
        <ol>
            <li>Lindhurst, M. J., et al. (2011). A mosaic activating mutation in AKT1 associated with the Proteus syndrome. New England Journal of Medicine, 365(7), 611-619.</li>
            <li>Turner, J. T., Cohen Jr, M. M., & Biesecker, L. G. (2004). Reassessment of the Proteus syndrome literature: application of diagnostic criteria to published cases. American Journal of Medical Genetics Part A, 130(2), 111-122.</li>
            <li>Biesecker, L. (2006). The challenges of Proteus syndrome: diagnosis and management. European Journal of Human Genetics, 14(11), 1151-1157.</li>
            <li>Cohen Jr, M. M. (2014). Proteus syndrome review: molecular, clinical, and pathologic features. Clinical Genetics, 85(2), 111-119.</li>
            <li>Keppler‐Noreuil, K. M., et al. (2014). Clinical delineation and natural history of the PIK3CA‐related overgrowth spectrum. American Journal of Medical Genetics Part A, 164(7), 1713-1733.</li>
        </ol>
    </div>
</body>
</html>
